NCT03728335
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03728335
Title Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
Moffitt Cancer Center ACTIVE_NOT_RECRUITING Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field